Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Lymphoma"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 255468

Starter badań:

Tytuł:
Diagnosis and management of ALK-positive anaplastic large cell lymphoma in children and adolescents.
Autorzy:
Rigaud C; Department of Children and Adolescents Oncology, Gustave Roussy Cancer Campus, Paris-Saclay University, Villejuif, France. Electronic address: .
Knörr F; NHL-BFM Study Centre and Pediatric Hematology and Oncology, University Medical Centre Hamburg-Eppendorf, 20246, Hamburg, Germany; Mildred Scheel Cancer Career Centre HaTriCS4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: .
Brugières L; Department of Children and Adolescents Oncology, Gustave Roussy Cancer Campus, Paris-Saclay University, Villejuif, France. Electronic address: .
Woessmann W; NHL-BFM Study Centre and Pediatric Hematology and Oncology, University Medical Centre Hamburg-Eppendorf, 20246, Hamburg, Germany. Electronic address: .
Pokaż więcej
Źródło:
Best practice & research. Clinical haematology [Best Pract Res Clin Haematol] 2023 Mar; Vol. 36 (1), pp. 101444. Date of Electronic Publication: 2023 Feb 02.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Lymphoma, Large-Cell, Anaplastic*/diagnosis
Lymphoma, Large-Cell, Anaplastic*/drug therapy
Lymphoma, Large-Cell, Anaplastic*/pathology
Child ; Humans ; Adolescent ; Receptor Protein-Tyrosine Kinases/metabolism ; Receptor Protein-Tyrosine Kinases/therapeutic use ; Anaplastic Lymphoma Kinase/therapeutic use ; Vinblastine/therapeutic use ; Neoplasm Recurrence, Local
Czasopismo naukowe
Szczegóły
Tytuł:
ALK-positive Large B-Cell Lymphoma Presenting as a Circumscribed Breast Mass with Germinal Center Immunophenotype.
Autorzy:
Yan M; Department of Pathology, 24575University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Khattab R; Department of Pathology, 24575University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Meyerson H; Department of Pathology, 24575University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2023 Apr; Vol. 31 (2), pp. 233-238. Date of Electronic Publication: 2022 May 06.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Lymphoma, Large B-Cell, Diffuse*/diagnosis
Lymphoma, Large B-Cell, Diffuse*/genetics
Female ; Humans ; Germinal Center/pathology ; Anaplastic Lymphoma Kinase
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Observation of Alectinib- and Crizotinib- included chemotherapy in children with ALK-positive anaplastic large cell lymphoma: A single institutional experience.
Autorzy:
He Y; Department of Pediatric Hematology & Oncology, Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China.
Pei K; Department of Pediatric Hematology & Oncology, Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China.; Guangzhou Medical University, Guangzhou, Guangdong, China.
Zhang H; Department of Pediatric Hematology & Oncology, Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China.
Wang J; Department of Pediatric Hematology & Oncology, Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China.
Su X; Department of Pediatric Hematology & Oncology, Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China.
Gan W; Department of Pediatric Hematology & Oncology, Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China.
Wang P; Department of Pediatric Hematology & Oncology, Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Mar; Vol. 12 (6), pp. 7182-7188. Date of Electronic Publication: 2022 Nov 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphoma, Large-Cell, Anaplastic*/drug therapy
Lymphoma, Large-Cell, Anaplastic*/pathology
Lung Neoplasms*/pathology
Humans ; Child ; Crizotinib/therapeutic use ; Neoplasm Recurrence, Local/drug therapy ; Anaplastic Lymphoma Kinase ; Protein Kinase Inhibitors/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma.
Autorzy:
Knörr F; Pediatric Hematology and Oncology, University Medical Center Hospital Hamburg-Eppendorf, Hamburg, Germany; Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, Hamburg. .
Schellekens KPJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Erasmus Medical Center, Sophia Children's Hospital, Rotterdam.
Schoot RA; Princess Máxima Center for Pediatric Oncology, Utrecht.
Landman-Parker J; Pediatric Hematology, Immunology, Oncology, Sorbonne université, Hôpital Armand Trousseau, APHP, Paris.
Teltschik HM; Pediatrics 5 (Oncology, Hematology, and Immunology), Olgahospital, Stuttgart.
Förster J; Pediatric Hematology and Oncology, University Medical Center Hospital Hamburg-Eppendorf, Hamburg.
Riquelme A; Pediatric Hematology and Oncology, University Medical Center Hospital Hamburg-Eppendorf, Hamburg.
Huitema ADR; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Dept. Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Dept. Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht.
Van Eijkelenburg NKA; Princess Máxima Center for Pediatric Oncology, Utrecht.
Beishuizen A; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Erasmus Medical Center, Sophia Children's Hospital, Rotterdam.
Zwaan CM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Erasmus Medical Center, Sophia Children's Hospital, Rotterdam.
Woessmann W; Pediatric Hematology and Oncology, University Medical Center Hospital Hamburg-Eppendorf, Hamburg.
Van der Lugt J; Princess Máxima Center for Pediatric Oncology, Utrecht.
Pokaż więcej
Źródło:
Haematologica [Haematologica] 2023 May 01; Vol. 108 (5), pp. 1442-1446. Date of Electronic Publication: 2023 May 01.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Vinblastine*
Lymphoma, Large-Cell, Anaplastic*/pathology
Child ; Humans ; Crizotinib ; Receptor Protein-Tyrosine Kinases ; Anaplastic Lymphoma Kinase
Raport
Szczegóły
Tytuł:
A rare case of primary cutaneous-anaplastic large cell lymphoma (PC-ALCL) localized to the eyelid.
Autorzy:
Atmaja B; The Royal Marsden Hospital, London and Sutton, UK.
Millard T; The Royal Marsden Hospital, London and Sutton, UK.
Wotherspoon A; The Royal Marsden Hospital, London and Sutton, UK.
Attygalle AD; The Royal Marsden Hospital, London and Sutton, UK.
Cunningham D; The Royal Marsden Hospital, London and Sutton, UK.; The Institute of Cancer Research, London and Sutton, UK.
Sharma B; The Royal Marsden Hospital, London and Sutton, UK.; The Institute of Cancer Research, London and Sutton, UK.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2023 Mar; Vol. 200 (5), pp. 539. Date of Electronic Publication: 2022 Nov 29.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Lymphoma, Large-Cell, Anaplastic*/pathology
Skin Neoplasms*/diagnosis
Skin Neoplasms*/etiology
Skin Neoplasms*/pathology
Humans ; Anaplastic Lymphoma Kinase ; Ki-1 Antigen ; Eyelids/pathology
Czasopismo naukowe
Szczegóły
Tytuł:
Anaplastic lymphoma kinase positive histiocytosis presenting as hemocytopenia in an infant.
Autorzy:
Wang W; Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, Beijing, China.; National Key Discipline of Pediatrics, Capital Medical University, Beijing, China.; Key Laboratory of Major Disease in Children, Ministry of Education, Beijing, China.; Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
He L; Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, Beijing, China.; National Key Discipline of Pediatrics, Capital Medical University, Beijing, China.; Key Laboratory of Major Disease in Children, Ministry of Education, Beijing, China.; Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Wu R; Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, Beijing, China.; National Key Discipline of Pediatrics, Capital Medical University, Beijing, China.; Key Laboratory of Major Disease in Children, Ministry of Education, Beijing, China.; Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Yao J; Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, Beijing, China.; National Key Discipline of Pediatrics, Capital Medical University, Beijing, China.; Key Laboratory of Major Disease in Children, Ministry of Education, Beijing, China.; Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Ma H; Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, Beijing, China.; National Key Discipline of Pediatrics, Capital Medical University, Beijing, China.; Key Laboratory of Major Disease in Children, Ministry of Education, Beijing, China.; Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Cheng X; Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, Beijing, China.; National Key Discipline of Pediatrics, Capital Medical University, Beijing, China.; Key Laboratory of Major Disease in Children, Ministry of Education, Beijing, China.; Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Wei A; Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, Beijing, China.; National Key Discipline of Pediatrics, Capital Medical University, Beijing, China.; Key Laboratory of Major Disease in Children, Ministry of Education, Beijing, China.; Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Lian H; Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, Beijing, China.; National Key Discipline of Pediatrics, Capital Medical University, Beijing, China.; Key Laboratory of Major Disease in Children, Ministry of Education, Beijing, China.; Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Wang D; Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, Beijing, China.; National Key Discipline of Pediatrics, Capital Medical University, Beijing, China.; Key Laboratory of Major Disease in Children, Ministry of Education, Beijing, China.; Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Li Z; Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, Beijing, China.; National Key Discipline of Pediatrics, Capital Medical University, Beijing, China.; Key Laboratory of Major Disease in Children, Ministry of Education, Beijing, China.; Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.; Hematologic Disease Laboratory, Beijing Pediatric Research Institute, Beijing, China.
Wang T; Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, Beijing, China.; National Key Discipline of Pediatrics, Capital Medical University, Beijing, China.; Key Laboratory of Major Disease in Children, Ministry of Education, Beijing, China.; Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Zhang R; Hematology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, Beijing, China.; National Key Discipline of Pediatrics, Capital Medical University, Beijing, China.; Key Laboratory of Major Disease in Children, Ministry of Education, Beijing, China.; Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.
Pokaż więcej
Źródło:
Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Mar; Vol. 70 (3), pp. e30010. Date of Electronic Publication: 2022 Oct 02.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Histiocytosis*
Lymphoma, Large-Cell, Anaplastic*/pathology
Humans ; Infant ; Anaplastic Lymphoma Kinase
Raport
Szczegóły
Tytuł:
Extensive histiocytosis masking anaplastic large-cell lymphoma (ALCL).
Autorzy:
Wentzell S; Department of Laboratory Hematology, Laboratory Medicine Program, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Morash B; Department of Laboratory Hematology, Laboratory Medicine Program, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Chang H; Department of Laboratory Hematology, Laboratory Medicine Program, University Health Network, University of Toronto, Toronto, Ontario, Canada.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2023 Jun; Vol. 201 (5), pp. 805. Date of Electronic Publication: 2023 Mar 23.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphoma, Large-Cell, Anaplastic*/diagnosis
Lymphoma, Large-Cell, Anaplastic*/pathology
Histiocytosis*
Humans ; Anaplastic Lymphoma Kinase
Czasopismo naukowe
Szczegóły
Tytuł:
Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphoma.
Autorzy:
Jiang VC; Department of Lymphoma and Myeloma and.
Liu Y; Department of Lymphoma and Myeloma and.
Lian J; Department of Lymphoma and Myeloma and.
Huang S; Department of Lymphoma and Myeloma and.
Jordan A; Department of Lymphoma and Myeloma and.
Cai Q; Department of Lymphoma and Myeloma and.
Lin R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Yan F; Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
McIntosh J; Department of Lymphoma and Myeloma and.
Li Y; Department of Lymphoma and Myeloma and.
Che Y; Department of Lymphoma and Myeloma and.
Chen Z; Department of Lymphoma and Myeloma and.
Vargas J; Department of Lymphoma and Myeloma and.
Badillo M; Department of Lymphoma and Myeloma and.
Bigcal JN; Department of Lymphoma and Myeloma and.
Lee HH; Department of Lymphoma and Myeloma and.
Wang W; Department of Lymphoma and Myeloma and.
Yao Y; Department of Lymphoma and Myeloma and.
Nie L; Department of Lymphoma and Myeloma and.
Flowers CR; Department of Lymphoma and Myeloma and.
Wang M; Department of Lymphoma and Myeloma and.; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło:
The Journal of clinical investigation [J Clin Invest] 2023 Feb 01; Vol. 133 (3). Date of Electronic Publication: 2023 Feb 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Protein-Tyrosine Kinases*/metabolism
Lymphoma, Mantle-Cell*/drug therapy
Lymphoma, Mantle-Cell*/genetics
Humans ; Adult ; Agammaglobulinaemia Tyrosine Kinase/genetics ; Cell Line, Tumor ; Phosphatidylinositol 3-Kinases ; Drug Resistance, Neoplasm/genetics ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein/genetics
Czasopismo naukowe
Szczegóły
Tytuł:
Discovery of orally bioavailable inhibitors of MALT1 with in vivo activity for psoriasis.
Autorzy:
Nunettsu Asaba K; Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan. Electronic address: .
Okimura K; Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan.
Adachi Y; Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan.
Tokumaru K; Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan. Electronic address: .
Goto Y; Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan.
Fujii S; Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan.
Watanabe A; Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan.
Sakai C; Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan.
Sakurada E; Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan.
Amikura K; Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan.
Aoki T; Pharmaceutical Research Laboratories, Toray Industries, Inc., 6-10-1 Tebiro, Kamakura, Kanagawa 248-8555, Japan.
Pokaż więcej
Źródło:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2023 Feb 15; Vol. 82, pp. 129155. Date of Electronic Publication: 2023 Jan 30.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphoma, B-Cell, Marginal Zone*
Psoriasis*/chemically induced
Psoriasis*/drug therapy
Mice ; Animals ; Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein
Czasopismo naukowe
Szczegóły
Tytuł:
The elusive but classic presentation of small cell variant of ALK+ anaplastic large cell lymphoma (ALCL).
Autorzy:
Kozak M; Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Eno C; Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Vail E; Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Kitahara S; Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Pokaż więcej
Źródło:
American journal of hematology [Am J Hematol] 2023 Feb; Vol. 98 (2), pp. 368-370. Date of Electronic Publication: 2021 Nov 13.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Lymphoma, Large-Cell, Anaplastic*/pathology
Humans ; Anaplastic Lymphoma Kinase ; Receptor Protein-Tyrosine Kinases/genetics
Czasopismo naukowe
Szczegóły
Tytuł:
Regulation of gingival keratinocyte monocyte chemoattractant protein-1-induced protein (MCPIP)-1 and mucosa-associated lymphoid tissue lymphoma translocation protein (MALT)-1 expressions by periodontal bacteria, lipopolysaccharide, and interleukin-1β.
Autorzy:
Firatli Y; Department of Periodontology, Institute of Dentistry, University of Turku, Turku, Finland.; Department of Periodontology, Faculty of Dentistry, Istanbul University, Istanbul, Turkey.
Firatli E; Department of Periodontology, Faculty of Dentistry, Istanbul University, Istanbul, Turkey.
Loimaranta V; Department of Periodontology, Institute of Dentistry, University of Turku, Turku, Finland.
Elmanfi S; Department of Periodontology, Institute of Dentistry, University of Turku, Turku, Finland.
Gürsoy UK; Department of Periodontology, Institute of Dentistry, University of Turku, Turku, Finland.
Pokaż więcej
Źródło:
Journal of periodontology [J Periodontol] 2023 Jan; Vol. 94 (1), pp. 130-140. Date of Electronic Publication: 2022 Aug 04.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lipopolysaccharides*/pharmacology
Lipopolysaccharides*/metabolism
Lymphoma, B-Cell, Marginal Zone*/metabolism
Humans ; Interleukin-1beta/metabolism ; Chemokine CCL2/metabolism ; Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein/metabolism ; Gingiva/metabolism ; Porphyromonas gingivalis/metabolism ; Fusobacterium nucleatum/physiology ; Keratinocytes/metabolism ; RNA, Messenger/metabolism
Czasopismo naukowe
Szczegóły
Tytuł:
Histone deacetylases inhibitor chidamide synergizes with humanized PD1 antibody to enhance T-cell chemokine expression and augment Ifn-γ response in NK-T cell lymphoma.
Autorzy:
Wen T; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Sun G; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Jiang W; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
He X; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Shi Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. Electronic address: .
Ma F; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. Electronic address: .
Liu P; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. Electronic address: .
Pokaż więcej
Źródło:
EBioMedicine [EBioMedicine] 2023 Jan; Vol. 87, pp. 104420. Date of Electronic Publication: 2022 Dec 31.
Typ publikacji:
Journal Article
MeSH Terms:
Chemokines*/metabolism
Interferon-gamma*/drug effects
Interferon-gamma*/metabolism
Lymphoma, T-Cell*/drug therapy
Animals ; Humans ; Mice ; Antibodies/pharmacology ; Antibodies/therapeutic use ; CD8-Positive T-Lymphocytes/drug effects ; CD8-Positive T-Lymphocytes/metabolism ; Cell Line, Tumor ; Histone Deacetylase Inhibitors/pharmacology ; Histone Deacetylase Inhibitors/therapeutic use ; Histone Deacetylases ; Lymphoma/drug therapy ; Neoplasm Recurrence, Local/drug therapy ; Programmed Cell Death 1 Receptor/immunology ; Programmed Cell Death 1 Receptor/metabolism
Czasopismo naukowe
Szczegóły
Tytuł:
The role of the CBM complex in allergic inflammation and disease.
Autorzy:
DeVore SB; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio; Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Cincinnati, Ohio.
Khurana Hershey GK; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio; Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Cincinnati, Ohio. Electronic address: .
Pokaż więcej
Źródło:
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2022 Nov; Vol. 150 (5), pp. 1011-1030. Date of Electronic Publication: 2022 Aug 16.
Typ publikacji:
Journal Article; Review; Research Support, N.I.H., Extramural
MeSH Terms:
Lymphoma, B-Cell, Marginal Zone*
Leukemia*
Humans ; B-Cell CLL-Lymphoma 10 Protein/metabolism ; CARD Signaling Adaptor Proteins ; Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein/metabolism ; Guanylate Cyclase ; Signal Transduction ; Inflammation ; Apoptosis Regulatory Proteins/metabolism ; NF-kappa B/metabolism ; Membrane Proteins/metabolism
Czasopismo naukowe
Szczegóły
Tytuł:
Endoscopic submucosal dissection for protruding Helicobacter pylori-negative mucosa-associated lymphoid tissue lymphoma of the stomach: a case report.
Autorzy:
Seya M; Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine Graduate School of Medical Science, 465 Kawaramachi Hirokoji Kamigyo-ku, Kyoto, 602-8566, Japan.
Dohi O; Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine Graduate School of Medical Science, 465 Kawaramachi Hirokoji Kamigyo-ku, Kyoto, 602-8566, Japan. .
Yamauchi K; Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine Graduate School of Medical Science, 465 Kawaramachi Hirokoji Kamigyo-ku, Kyoto, 602-8566, Japan.
Fukui H; Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine Graduate School of Medical Science, 465 Kawaramachi Hirokoji Kamigyo-ku, Kyoto, 602-8566, Japan.
Miyazaki H; Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine Graduate School of Medical Science, 465 Kawaramachi Hirokoji Kamigyo-ku, Kyoto, 602-8566, Japan.
Yasuda T; Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine Graduate School of Medical Science, 465 Kawaramachi Hirokoji Kamigyo-ku, Kyoto, 602-8566, Japan.
Inoue K; Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine Graduate School of Medical Science, 465 Kawaramachi Hirokoji Kamigyo-ku, Kyoto, 602-8566, Japan.
Yoshida N; Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine Graduate School of Medical Science, 465 Kawaramachi Hirokoji Kamigyo-ku, Kyoto, 602-8566, Japan.
Morinaga Y; Department of Surgical Pathology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Itoh Y; Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine Graduate School of Medical Science, 465 Kawaramachi Hirokoji Kamigyo-ku, Kyoto, 602-8566, Japan.
Pokaż więcej
Źródło:
Clinical journal of gastroenterology [Clin J Gastroenterol] 2022 Oct; Vol. 15 (5), pp. 881-885. Date of Electronic Publication: 2022 Aug 02.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Endoscopic Mucosal Resection*/adverse effects
Helicobacter Infections*/complications
Helicobacter pylori*
Lymphoma, B-Cell, Marginal Zone*/diagnostic imaging
Lymphoma, B-Cell, Marginal Zone*/surgery
Stomach Neoplasms*/diagnosis
Gastric Mucosa/pathology ; Gastric Mucosa/surgery ; Humans ; Lymphoma, Non-Hodgkin ; Male ; Middle Aged ; Stomach/pathology
SCR Disease Name:
Familial primary gastric lymphoma
Czasopismo naukowe
Szczegóły
Tytuł:
Primary ALK-Positive Large B Cell Lymphoma of Pancreas.
Autorzy:
Kushwaha P; Department of Pathology, Maulana Azad Medical College, New Delhi, India.
Singh M; Department of Pathology, Maulana Azad Medical College, New Delhi, India. .
Vindal A; Department of Surgery, Maulana Azad Medical College, New Delhi, India.
Verma N; Department of Pathology, Maulana Azad Medical College, New Delhi, India.
Jain S; Department of Pathology, Maulana Azad Medical College, New Delhi, India.
Pokaż więcej
Źródło:
Journal of gastrointestinal cancer [J Gastrointest Cancer] 2022 Sep; Vol. 53 (3), pp. 830-833. Date of Electronic Publication: 2021 Aug 10.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Lymphoma, Large B-Cell, Diffuse*/diagnosis
Lymphoma, Large B-Cell, Diffuse*/pathology
Receptor Protein-Tyrosine Kinases*/metabolism
Abdomen/pathology ; Anaplastic Lymphoma Kinase ; Bilirubin ; Female ; Humans ; Pancreas/diagnostic imaging ; Pancreas/surgery
Czasopismo naukowe
Szczegóły
Tytuł:
Chemotherapy-induced pericarditis in anaplastic large cell lymphoma patient.
Autorzy:
Filizoglu N; Department of Nuclear Medicine, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey. Electronic address: .
Ozguven S; Department of Nuclear Medicine, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Ones T; Department of Nuclear Medicine, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Turoglu HT; Department of Nuclear Medicine, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Erdil TY; Department of Nuclear Medicine, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey.
Pokaż więcej
Źródło:
Revista espanola de medicina nuclear e imagen molecular [Rev Esp Med Nucl Imagen Mol (Engl Ed)] 2022 Nov-Dec; Vol. 41 (6), pp. 389-390. Date of Electronic Publication: 2021 Aug 01.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphoma, Large-Cell, Anaplastic*/diagnostic imaging
Lymphoma, Large-Cell, Anaplastic*/drug therapy
Lymphoma, Large-Cell, Anaplastic*/pathology
Antineoplastic Agents*/adverse effects
Pericarditis*/chemically induced
Pericarditis*/diagnostic imaging
Humans ; Anaplastic Lymphoma Kinase ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Czasopismo naukowe
Szczegóły
Tytuł:
Profound and sustained response with next-generation ALK inhibitors in patients with relapsed or progressive ALK-positive anaplastic large cell lymphoma with central nervous system involvement.
Autorzy:
Rigaud C; Department of Children and Adolescents Oncology, Gustave Roussy Cancer Center, Paris-Saclay University, Villejuif. .
Abbou S; Department of Children and Adolescents Oncology, Gustave Roussy Cancer Center, Paris-Saclay University, Villejuif.
Ducassou S; Department of Pediatric Oncology and Hematology, Bordeaux University hospital, Bordeaux.
Simonin M; Department of Pediatric Oncology and Hematology, Armand Trousseau Hospital- APHP, Paris.
Le Mouel L; Department of Pediatric Hematology, Robert Debré Hospital- APHP, Paris.
Pereira V; Department of Pediatric Oncology and Hematology, Besançon University Hospital, Besançon.
Gourdon S; Department of Pediatric Oncology and Hematology, Saint-Denis de la Réunion University Hospital.
Lambilliotte A; Department of Pediatric Hematology, Lille University Hospital, Lille.
Geoerger B; Department of Children and Adolescents Oncology, Gustave Roussy Cancer Center, Paris-Saclay University, Villejuif.
Minard-Colin V; Department of Children and Adolescents Oncology, Gustave Roussy Cancer Center, Paris-Saclay University, Villejuif.
Brugieres L; Department of Children and Adolescents Oncology, Gustave Roussy Cancer Center, Paris-Saclay University, Villejuif.
Pokaż więcej
Źródło:
Haematologica [Haematologica] 2022 Sep 01; Vol. 107 (9), pp. 2255-2260. Date of Electronic Publication: 2022 Sep 01.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphoma, Large-Cell, Anaplastic*/drug therapy
Lymphoma, Large-Cell, Anaplastic*/pathology
Anaplastic Lymphoma Kinase/genetics ; Central Nervous System/pathology ; Humans ; Protein Kinase Inhibitors/therapeutic use
Czasopismo naukowe
Szczegóły
Tytuł:
Digestive tract MALT lymphoma, an unusual location.
Autorzy:
Correia J; Gastroenterology, Centro Hospitalar de Vila Nova de Gaia/Espinho, Portugal.
Pimenta M; Hematology , Instituto de Português de Oncologia do Porto Francisco Gentil.
Ponte A; Gastrenterology, Centro Hospitalar de Vila Nova de Gaia/Espinho.
Afecto E; Gastrenterology, Centro Hospitalar de Vila Nova de Gaia/Espinho, Portugal.
Estevinho M; Gastrenterology, Centro Hospitalar de Vila Nova de Gaia/Espinho.
Mesquita P; Gastroenterology , Centro Hospitalar de Vila Nova de Gaia/Espinho.
Freitas T; Gastroenterology , Centro Hospitalar de Vila Nova de Gaia/Espinho.
Pokaż więcej
Źródło:
Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva [Rev Esp Enferm Dig] 2022 Sep; Vol. 114 (9), pp. 562-563.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Lymphoma, B-Cell, Marginal Zone*/diagnostic imaging
Lymphoma, B-Cell, Marginal Zone*/therapy
Stomach Neoplasms*/pathology
Aged ; Female ; Gastrointestinal Hemorrhage ; Humans ; Lymphoma, Non-Hodgkin
SCR Disease Name:
Familial primary gastric lymphoma
Raport
Szczegóły
Tytuł:
Donor-origin anaplastic lymphoma kinase driver-positive inflammatory myofibroblastic tumor after umbilical cord blood transplantation in pediatric acute lymphoblastic leukemia.
Autorzy:
Horiguchi A; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
Arakawa Y; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
Noguchi J; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
Mori M; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
Oshima K; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
Iwama I; Department of Gastroenterology and Hepatology, Saitama Children's Medical Center, Saitama, Japan.
Kawashima H; Department of Surgery, Saitama Children's Medical Center, Saitama, Japan.
Tanami Y; Department of Radiology, Saitama Children's Medical Center, Saitama, Japan.
Nakazawa A; Department of Clinical Research, Saitama Children's Medical Center, Saitama, Japan.
Koh K; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
Pokaż więcej
Źródło:
Pediatric blood & cancer [Pediatr Blood Cancer] 2022 Nov; Vol. 69 (11), pp. e29708. Date of Electronic Publication: 2022 Apr 20.
Typ publikacji:
Letter
MeSH Terms:
Cord Blood Stem Cell Transplantation*/adverse effects
Hematopoietic Stem Cell Transplantation*
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy
Anaplastic Lymphoma Kinase ; Child ; Humans ; Tissue Donors
Opinia redakcyjna
Szczegóły
Tytuł:
Patient characteristics and outcome of CD20-positive HIV-associated lymphoma: a single-center KwaZulu-Natal, South African hospital 12-year retrospective review.
Autorzy:
Rapiti N; Department of Haematology, NHLS/University of KwaZulu Natal/King Edward VIII Hospital, Durban, South Africa. .
Abdelatif N; Biostatistics Research Unit, South African Medical Research Council, Durban, South Africa.
Rapiti A; Department of Neurosurgery, Inkosi Albert Luthuli Central Hospital, Durban, South Africa.
Moosa MY; Department of Infectious Diseases, University of KwaZulu-Natal, Durban, South Africa.
Pokaż więcej
Źródło:
Journal of the Egyptian National Cancer Institute [J Egypt Natl Canc Inst] 2022 Aug 01; Vol. 34 (1), pp. 32. Date of Electronic Publication: 2022 Aug 01.
Typ publikacji:
Journal Article; Review
MeSH Terms:
HIV Infections*/epidemiology
Lymphoma*/chemically induced
Lymphoma*/drug therapy
Lymphoma*/epidemiology
Adult ; Antibodies, Monoclonal, Murine-Derived/adverse effects ; Antibodies, Monoclonal, Murine-Derived/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cyclophosphamide/therapeutic use ; Doxorubicin/adverse effects ; Doxorubicin/therapeutic use ; Female ; HIV ; Hospitals ; Humans ; Lymphoma, Large B-Cell, Diffuse/drug therapy ; Male ; Prednisone/adverse effects ; Prednisone/therapeutic use ; Retrospective Studies ; Rituximab/therapeutic use ; South Africa/epidemiology ; Treatment Outcome ; Vincristine/therapeutic use
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 255468

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies